7347-97-9

Basic information

• Product Name: 2-METHYL-1,3-THIAZOLIDINE-4-CARBOXYLIC ACID
• Synonyms: 2-METHYL-1,3-THIAZOLANE-4-CARBOXYLIC ACID;2-METHYL-1,3-THIAZOLIDINE-4-CARBOXYLIC ACID;2-METHYL-THIAZOLIDINE-4-CARBOXYLIC ACID
• CAS NO: 7347-97-9
• Molecular Formula: C5H9NO2S
• Molecular Weight: 147.2
• Mol File: 7347-97-9.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 333°C at 760 mmHg
• Flash Point: 155.2°C
• Appearance: /
• Density: 1.263g/cm³
• Vapor Pressure: 2.71E-05mmHg at 25°C
• Refractive Index: 1.533
• Storage Temp.: Refrigerator
• Solubility: DMSO (Slightly), Methanol (Slightly, Heated)
• CAS DataBase Reference: 2-METHYL-1,3-THIAZOLIDINE-4-CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 2-METHYL-1,3-THIAZOLIDINE-4-CARBOXYLIC ACID(7347-97-9)
• EPA Substance Registry System: 2-METHYL-1,3-THIAZOLIDINE-4-CARBOXYLIC ACID(7347-97-9)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 7347-97-9(Hazardous Substances Data)

Usage

Uses

An Cysteine prodrug, protective aginst the fungal T-2 toxin. It is also a precursor to pharmaceuticals used in the treatment of cataracts.

InChI:InChI=1/C5H9NO2S/c1-3-6-4(2-9-3)5(7)8/h3-4,6H,2H2,1H3,(H,7,8)

Upstream product

• 75-07-0 acetaldehyde 
• 921-01-7 rac-cysteine 
• 52-89-1 l-cysteine hydrochloride 
• 52-90-4 L-Cysteine 
• 50-00-0 formaldehyd 
• 921-01-7 D-cysteine 

Downstream Products

• 107321-69-7 (R)-3-(2-Benzyloxycarbonylamino-acetyl)-2-methyl-thiazolidine-4-carboxylic acid 

Relevant articles and documents

(+)-Meyeniins A-C, Novel Hexahydroimidazo[1,5-c]thiazole Derivatives from the Tubers of Lepidium meyenii: Complete Structural Elucidation by Biomimetic Synthesis and Racemic Crystallization

(+)-Meyeniins A-C (1-3), a novel class of sulfur-containing hexahydroimidazo[1,5-c]thiazole derivatives, were isolated from the tubers of Lepidium meyenii (maca) cultivated in Lijiang, Yunnan province, China. Guided by their biosynthetic hypothesis, a ste

HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR INHIBITING LIPID ACCUMULATION CONTAINING SAME

The present invention relates to a novel heterocyclic carboxylic acid derivative, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same as an active ingredient for inhibiting the accumulation of lipids in the body.

Azafulvenium methides: New extended dipolar systems

The transient 8π 1,7-dipolar azafulvenium methides 5 and 8 undergo sigmatropic [1,8] H shifts and the acyl derivatives 12 electrocyclise to give novel pyrrolooxazines 13; the related diazafulvenium methide 15 can be intercepted in 8π + 2π cycloadditions with silylated acetylenes.